Casey Gashti is a Nephrology physician affiliated with Rush University Medical Center. OpenAlex indexes 25 publications with 265 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
104 S Ashland Ave
Chicago, IL 606072402
Telephone
312-850-8434Provider last certified this registry record 29 Apr 2025.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- NxStage Medical, Inc.Program year20257 payments
- Fresenius USA Marketing, Inc.Program year20253 payments
- Amgen Inc.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
73.5%Loop diuretic20.8%Furosemide71%Bumetanide29%Part D<11 patientsCalcium channel blocker20.8%Amlodipine Besylate74%Nifedipine Er26%Part D<11 patients+ 3 more classes in this area
Musculoskeletal
6.8%Xanthine oxidase inhibitor6.8%Allopurinol100%Part D<11 patientsMetabolism & gastrointestinal
5.4%SGLT2 inhibitor5.4%Jardiance100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- “A Change Is Gonna Come” to Treatment of Lupus Nephritis: A Review
American Journal of Kidney Diseases
2025 - Immune Checkpoint Inhibitor-Induced “Pantubulopathy”
Journal of the American Society of Nephrology
2022 - PLAR2-Positive Membranous Nephropathy: A Renal Manifestation of Scleromyxedema
Journal of the American Society of Nephrology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Christopher Goetz, MD
Rush University Medical Center
Theodore Pincus, MD
Rush University Medical Center
Christopher Seder, MD
Rush University Medical Center
Melody Cobleigh, MD
Rush University Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”